A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the long-term safety, tolerability, and efficacy
of MP-214 in patients with chronic phase or elderly schizophrenia.